Sequential Treatment with Bevacizumab and Aflibercept for Metastatic Colorectal Cancer in Real-World Clinical Practice.

导出原文传递

翻译打印收藏纠错

作者： Tomas,Buchler ^[1] ; Igor,Kiss ^[2] ; Jana,Hornova ^[3] ; Ondrej,Fiala ^[4] ; Marketa,Wiesnerova ^[5] ; Michal,Svoboda ^[6] ; Jiri,Silar ^[6] ; Katerina,Kopeckova ^[6] ; Alexandr,Poprach ^[7] ; Jindrich,Finek ^[2] ; Lubos,Petruzelka ^[4] ; Bohuslav,Melichar ^[8]

作者单位： Department of Oncology, First Faculty of Medicine, Charles University, Thomayer University Hospital, Videnska 800, 140 59, Prague, Czech Republic. tomas.buchler@ftn.cz. ^[1] Department of Comprehensive Cancer Care, Faculty of Medicine, Masaryk Memorial Cancer Institute, Masaryk University, Zluty Kopec 543/7, 656 53, Brno, Czech Republic. ^[2] Department of Oncology, First Faculty of Medicine, Charles University, Thomayer University Hospital, Videnska 800, 140 59, Prague, Czech Republic. ^[3] Department of Oncology and Radiotherapeutics, University Hospital in Pilsen, Alej Svobody 80, 304 60, Pilsen, Czech Republic. ^[4] Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 76, 323 00, Pilsen, Czech Republic. ^[5] Institute of Biostatistics and Analyses, Poštovská 68/3, 602 00, Brno, Czech Republic. ^[6] Department of Oncology, Motol University Hospital, Second Faculty of Medicine, Charles University, V Uvalu 84, 150 00, Prague, Czech Republic. ^[7] Department of Oncology, General University Hospital, Charles University First Faculty of Medicine, U Nemocnice 499/2, 128 08, Prague, Czech Republic. ^[8] Department of Oncology, Palacky University Medical School and Teaching Hospital, I.P. Pavlova 6, 775 20, Olomouc, Czech Republic. ^[9]